2025
The Role of the Interventional Radiologist in Stopping Bleeding in Cancer Patients
Fish A, Madoff D. The Role of the Interventional Radiologist in Stopping Bleeding in Cancer Patients. Current Oncology Reports 2025, 27: 483-489. PMID: 40120057, DOI: 10.1007/s11912-025-01663-5.Peer-Reviewed Original ResearchUterine artery embolizationBronchial artery embolizationArtery embolizationBronchial arterial chemoembolizationMalignancy-related bleedingLife-threatening complicationsImproved long-term controlMultidisciplinary approachLong-term controlTumor bleedingArterial chemoembolizationSuperselective embolizationIschemic complicationsEmbolization techniquesInterventional radiologistsControl hemorrhageLung cancerHemostatic solutionsCancer patientsEmbolizationEndovascular interventionStop bleedingImprove outcomesBleedingHemorrhage
2023
Curcumin effects on chronic obstructive pulmonary disease: A systematic review
Safari S, Davoodi P, Soltani A, Fadavipour M, Rezaeian A, Heydari F, Tabari M, Akhlaghdoust M. Curcumin effects on chronic obstructive pulmonary disease: A systematic review. Health Science Reports 2023, 6: e1145. PMID: 36890804, PMCID: PMC9987200, DOI: 10.1002/hsr2.1145.Peer-Reviewed Original ResearchChronic obstructive pulmonary diseaseObstructive pulmonary diseaseSystematic review INTRODUCTIONChronic obstructive pulmonary disease managementHealth care workersSystematically review studiesPulmonary diseaseWeb of SciencePreventing ischemic complicationsNon-English publicationsPRISMA checklistIn vivoCare workersFrequent COPD exacerbationsRandomized clinical trialsAnti-inflammatory effectsConference abstractsIschemic complicationsEpithelial thicknessAirway inflammationCOPD exacerbationsClinical trialsIn vitro researchReview IntroductionInflammatory response
2018
Risk of Branch Occlusion and Ischemic Complications with the Pipeline Embolization Device in the Treatment of Posterior Circulation Aneurysms
Adeeb N, Griessenauer C, Dmytriw A, Shallwani H, Gupta R, Foreman P, Shakir H, Moore J, Limbucci N, Mangiafico S, Kumar A, Michelozzi C, Zhang Y, Pereira V, Matouk C, Harrigan M, Siddiqui A, Levy E, Renieri L, Marotta T, Cognard C, Ogilvy C, Thomas A. Risk of Branch Occlusion and Ischemic Complications with the Pipeline Embolization Device in the Treatment of Posterior Circulation Aneurysms. American Journal Of Neuroradiology 2018, 39: 1303-1309. PMID: 29880475, PMCID: PMC7655425, DOI: 10.3174/ajnr.a5696.Peer-Reviewed Original ResearchConceptsPosterior circulation aneurysmsPipeline Embolization DevicePosterior cerebral arteryIschemic complicationsInferior cerebellar arteryEmbolization DeviceVertebral arteryCerebellar arteryCerebral arteryBranch occlusionAnterior inferior cerebellar arteryPosterior inferior cerebellar arteryCohort of patientsContralateral vertebral arteryLow associated morbiditySuperior cerebellar arteryLong-term patencyAnterior circulationIschemic eventsAssociated morbidityConsecutive patientsPosterior circulationEndovascular treatmentMultivariable analysisRetrospective reviewTissue Oximetry during Cardiac Surgery and in the Cardiac Intensive Care Unit: A Prospective Observational Trial
Heller B, Deshpande P, Heller J, McCormick P, Lin H, Huang R, Fischer G, Weiner M. Tissue Oximetry during Cardiac Surgery and in the Cardiac Intensive Care Unit: A Prospective Observational Trial. Annals Of Cardiac Anaesthesia 2018, 21: 371-375. PMID: 30333329, PMCID: PMC6206809, DOI: 10.4103/aca.aca_105_17.Peer-Reviewed Original ResearchConceptsCerebral oximetry valuesIntensive care unitCardiac surgeryProspective observational trialOximetry valuesTissue oximetryParaspinal musclesCerebral oximetryObservational trialCare unitProlonged intensive care unitVascular ischemic complicationsCardiac intensive care unitAcute renal failureHospital length of stayFisher's exact testWilcoxon rank sum testStudent's t-testRank sum testLength of stayTissue oximetry valuesIschemic complicationsCardiopulmonary bypassRenal failureProlonged need
2016
Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions
Nakazaki M, Nonaka T, Takahashi A, Yonemasu Y, Nomura T, Onda T, Honda O, Hashimoto Y, Ohnishi H, Sasaki M, Daibo M, Honmou O. Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions. Acta Neurochirurgica 2016, 158: 1377-1386. PMID: 27138330, DOI: 10.1007/s00701-016-2816-2.Peer-Reviewed Original ResearchConceptsDouble balloon protectionCarotid artery stentingDistal balloon protectionDistal filter protectionBalloon protectionCarotid stenosisNew lesionsFilter protectionDistal protectionDiffusion-weighted imaging studiesNew brain lesionsProximal balloon occlusionResultsSixty-four patientsIndependent significant factorsPosterior cervical musclesLogistic regression analysisT1-weighted imagesIschemic complicationsEmbolic complicationsArtery stentingBalloon occlusionCervical musclesDWI findingsTarget lesionsOdds ratio
2015
Consequences of hypogastric artery ligation, embolization, or coverage
Chitragari G, Schlosser FJ, Chaar C, Sumpio BE. Consequences of hypogastric artery ligation, embolization, or coverage. Journal Of Vascular Surgery 2015, 62: 1340-1347.e1. PMID: 26386508, DOI: 10.1016/j.jvs.2015.08.053.Peer-Reviewed Original ResearchConceptsVascular surgery patientsHypogastric arteryIschemic complicationsVascular surgeryProximal interruptionSurgery patientsComplication rateMedian ageOncology patientsRisk factorsSignificant differencesHypogastric artery ligationIschemic complication rateDevelopment of complicationsSpinal cord ischemiaData of patientsClear risk factorsButtock claudicationButtock necrosisColonic ischemiaCord ischemiaBilateral embolizationDistal embolizationProximal embolizationControlled Trials
2013
Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial
Jang S, Park D, Kim W, Kim Y, Yun S, Kang S, Lee S, Lee C, Park S, Park S. Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial. Catheterization And Cardiovascular Interventions 2013, 81: 1106-1114. PMID: 22899589, DOI: 10.1002/ccd.24603.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiovascular AgentsChi-Square DistributionCoronary AngiographyCoronary Artery DiseaseCoronary ThrombosisDiabetes MellitusDrug-Eluting StentsFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMyocardial InfarctionPaclitaxelPercutaneous Coronary InterventionProportional Hazards ModelsProspective StudiesProsthesis DesignRepublic of KoreaRisk AssessmentRisk FactorsSirolimusTime FactorsTreatment OutcomeConceptsMajor adverse cardiac eventsPaclitaxel-eluting stentsZotarolimus-eluting stentsSirolimus-eluting stentsNondiabetic patientsDiabetic statusDiabetic patientsStent typeIschemia-driven target vessel revascularizationDifferential long-term outcomesLower ratesAdverse cardiac eventsComposite of deathTarget vessel revascularizationLong-term outcomesDifferential treatment effectsSimilar ratesAngiographic characteristicsIschemic complicationsCardiac eventsDiabetes mellitusPrimary outcomeMACE occurrenceStent groupMyocardial infarction
2012
Long-Term Clinical and Imaging Follow-Up of Complex Intracranial Aneurysms Treated by Endovascular Parent Vessel Occlusion
Matouk CC, Kaderali Z, terBrugge KG, Willinsky RA. Long-Term Clinical and Imaging Follow-Up of Complex Intracranial Aneurysms Treated by Endovascular Parent Vessel Occlusion. American Journal Of Neuroradiology 2012, 33: 1991-1997. PMID: 22555575, PMCID: PMC7964607, DOI: 10.3174/ajnr.a3079.Peer-Reviewed Original ResearchConceptsComplex intracranial aneurysmsMajor ischemic complicationsIntracranial aneurysmsVB aneurysmsIschemic complicationsObliteration rateEndovascular parent vessel occlusionMass effectParent vessel occlusionHigh obliteration ratesLower obliteration ratesHigh mortality rateFlow-diverting stentsTerm ClinicalAnterior circulationSignificant morbidityTreat lesionsSubarachnoid hemorrhageImaging outcomesPeripheral arteriesVessel occlusionCarotid arteryBest treatment techniqueEffective treatmentMortality rate
2011
Prognostic Significance of Coronary Thrombus in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes A Subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial
Goto K, Lansky AJ, Nikolsky E, Fahy M, Feit F, Ohman EM, White HD, Mehran R, Bertrand ME, Desmet W, Hamon M, Stone GW. Prognostic Significance of Coronary Thrombus in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes A Subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial. JACC Cardiovascular Interventions 2011, 4: 769-777. PMID: 21777885, DOI: 10.1016/j.jcin.2011.02.019.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionAcute coronary syndromeACUITY trialStent thrombosisMyocardial infarctionACS patientsCoronary interventionIndependent predictorsHigh-risk acute coronary syndromesSegment elevation acute coronary syndromesElevation acute coronary syndromeHigh-risk ACS patientsIndependent angiographic core laboratoryEpicardial coronary flowEarly invasive strategyRisk of deathHigh-risk populationAngiographic core laboratoryHigh rateBaseline angiographyCoronary syndromeIschemic complicationsAdjunctive pharmacotherapyCoronary thrombusPrognostic importanceIncidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: Results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial
Caixeta A, Dangas GD, Mehran R, Feit F, Nikolsky E, Lansky AJ, Aoki J, Moses JW, Steinhubl SR, White HD, Ohman EM, Manoukian SV, Fahy M, Stone GW. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: Results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. American Heart Journal 2011, 161: 298-306.e1. PMID: 21315212, DOI: 10.1016/j.ahj.2010.10.035.Peer-Reviewed Original ResearchConceptsIIb/IIIa inhibitorsGP IIb/IIIa inhibitorsAcute coronary syndromeBivalirudin monotherapyMajor bleedingCoronary syndromePlatelet countClinical consequencesUrgent Intervention Triage Strategy (ACUITY) trialGlycoprotein IIb/IIIa inhibitorsPredictors of mortalityAcquired thrombocytopeniaACUITY trialAcute CatheterizationAntiplatelet medicationsAntithrombotic therapyIschemic complicationsAnticoagulant regimenIndependent predictorsStrategy trialThrombocytopeniaPatientsMultivariate analysisMonotherapyLess decline
2010
Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes (an ACUITY Substudy)
Kirtane AJ, Parise H, Mehran R, Moses JW, Fahy M, Bertrand ME, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Ware JH, Pocock SJ, Lansky AJ, Stone GW. Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes (an ACUITY Substudy). The American Journal Of Cardiology 2010, 106: 180-186. PMID: 20599000, DOI: 10.1016/j.amjcard.2010.03.015.Peer-Reviewed Original ResearchConceptsAcute coronary syndromePercutaneous coronary interventionCoronary syndromeCoronary interventionTreatment selectionHigh-risk acute coronary syndromesUrgent Intervention Triage Strategy (ACUITY) trialGlycoprotein IIb/IIIa inhibitorsBaseline cardiac risk factorsNet clinical adverse eventsIIb/IIIa inhibitorsPrevious revascularization proceduresUse of abciximabCardiac risk factorsStudy end pointClinical adverse eventsImproved clinical outcomesST-segment deviationAcute CatheterizationComposite ischemiaMajor bleedingIschemic complicationsAdverse eventsBiomarker elevationRevascularization procedures
2009
Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical Implications Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial
Nikolsky E, Stone GW, Kirtane AJ, Dangas GD, Lansky AJ, McLaurin B, Lincoff AM, Feit F, Moses JW, Fahy M, Manoukian SV, White HD, Ohman EM, Bertrand ME, Cox DA, Mehran R. Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical Implications Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial. Journal Of The American College Of Cardiology 2009, 54: 1293-1302. PMID: 19778672, DOI: 10.1016/j.jacc.2009.07.019.Peer-Reviewed Original ResearchMeSH KeywordsAcute Coronary SyndromeAge FactorsAgedAngioplasty, Balloon, CoronaryAnticoagulantsClopidogrelCoronary Artery BypassFemaleGastrointestinal HemorrhageHeparinHirudinsHumansIncidenceIschemiaLength of StayMaleMiddle AgedMultivariate AnalysisMyocardial InfarctionPeptide FragmentsPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexRecombinant ProteinsRisk AssessmentSex FactorsStentsThrombosisTiclopidineConceptsAcute coronary syndromeGastrointestinal bleedingACUITY trialComposite ischemiaCardiac mortalityCause mortalityCoronary syndromeHigh-risk acute coronary syndromesStudy drug administrationOpen-label usePotential hemorrhagic complicationsST-segment deviationAntiplatelet medicationsBaseline anemiaHemorrhagic complicationsIschemic complicationsIndependent predictorsClinical outcomesMultivariable analysisStent thrombosisMyocardial infarctionSerious conditionPatientsDrug AdministrationOlder ageCerebral Ischemic Events Associated With ‘Bubble Study’ for Identification of Right to Left Shunts
Romero J, Frey J, Schwamm L, Demaerschalk B, Chaliki H, Parikh G, Burke R, Babikian V. Cerebral Ischemic Events Associated With ‘Bubble Study’ for Identification of Right to Left Shunts. Stroke 2009, 40: 2343-2348. PMID: 19498192, DOI: 10.1161/strokeaha.109.549683.Peer-Reviewed Original ResearchConceptsCerebral ischemic eventsIschemic eventsPatent foramenBubble studyIschemic strokePulmonary shuntEarly brain MRIIschemic Cerebrovascular ComplicationsCryptogenic ischemic strokeTransient ischemic attackEvaluation of patientsPulmonary arteriovenous malformationsDegree of disabilitySaline intravenous injectionCerebrovascular complicationsIschemic attackInfarct volumeIschemic complicationsRare complicationAcute infarctionClinical featuresTransient symptomsTrue incidenceReporting of drugDevice complications
2005
Impact of In-Hospital Acquired Thrombocytopenia in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction
Nikolsky E, Sadeghi HM, Effron MB, Mehran R, Lansky AJ, Na Y, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD, Grines CL, Stone GW. Impact of In-Hospital Acquired Thrombocytopenia in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction. The American Journal Of Cardiology 2005, 96: 474-481. PMID: 16098296, DOI: 10.1016/j.amjcard.2005.04.005.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAge DistributionAgedAngioplasty, Balloon, CoronaryAntibodies, MonoclonalCause of DeathFemaleFollow-Up StudiesHemorrhageHumansImmunoglobulin Fab FragmentsIncidenceInpatientsMaleMiddle AgedMyocardial InfarctionOdds RatioPlatelet Aggregation InhibitorsPlatelet CountProspective StudiesRisk FactorsSex DistributionSurvival RateThrombocytopeniaTreatment OutcomeConceptsPrimary percutaneous coronary interventionPercutaneous coronary interventionAcute myocardial infarctionHemorrhagic complicationsAcquired thrombocytopeniaPlatelet countMyocardial infarctionHigher baseline platelet countGreater body mass indexNadir platelet countPrevious aspirin useUse of abciximabBaseline platelet countBlood product transfusionLonger hospital stayMajor hemorrhagic complicationsHours of onsetBody mass indexAspirin useBaseline thrombocytopeniaCADILLAC trialIschemic complicationsCause mortalityHospital stayPrimary angioplastyPercutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women
Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, New G, Grines CL, Pietras CG, Kern MJ, Ferrell M, Leon MB, Mehran R, White C, Mieres JH, Moses JW, Stone GW, Jacobs AK. Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women. Circulation 2005, 111: 940-953. PMID: 15687113, DOI: 10.1161/01.cir.0000155337.50423.c9.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionCoronary interventionAdjunctive pharmacotherapyHigh-risk acute coronary syndromesContemporary interventional therapyNonfatal ischemic complicationsAcute coronary syndromeAcute myocardial infarctionSex-specific dataCoronary syndromeIschemic complicationsMyocardial infarctionInterventional therapyWomenPharmacotherapyInterventionComplicationsInfarctionSyndromeTherapy
2004
ATP-Induced Modulation of Norepinephrine Exocytosis in Human and Porcine Heart: Role of E-NTPDase1/CD39.
Machida T, Heerdt P, Reid A, Schaefer U, Silver R, Broekman M, Marcus A, Levi R. ATP-Induced Modulation of Norepinephrine Exocytosis in Human and Porcine Heart: Role of E-NTPDase1/CD39. Blood 2004, 104: 1869. DOI: 10.1182/blood.v104.11.1869.1869.Peer-Reviewed Original ResearchE-NTPDase1/CD39NE exocytosisSympathetic nerve terminalsNE releaseNovel therapeutic approachesMyocardial ischemiaNerve terminalsTherapeutic approachesCardiac sympathetic nerve terminalsCoronary vascular dysfunctionSympathetic nerve endingsIschemic heart diseaseActivation of ATPGuinea pig heartsImportant modulatory roleAnti-thrombotic agentsCause of dysfunctionDepolarization of synaptosomesRelease of ATPAdrenergic neurotransmissionCardiac neuronsIschemic complicationsSympathetic terminalsP2X purinoceptorsVascular dysfunctionComparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age
Lansky AJ, Mehran R, Dangas G, Cristea E, Shirai K, Costa R, Costantini C, Tsuchiya Y, Carlier S, Mintz G, Cottin Y, Stone G, Moses J, Leon MB. Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. The American Journal Of Cardiology 2004, 93: 916-919. PMID: 15050498, DOI: 10.1016/j.amjcard.2003.12.046.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionYears of ageCoronary interventionVascular complicationsMyocardial infarctionMortality rateAggressive risk factor modificationQ-wave myocardial infarctionHospital vascular complicationsMore diabetes mellitusPredominance of diabetesNonfatal myocardial infarctionRisk factor modificationPremature coronary diseaseRisk factor profileOnly independent predictorMultivariable regression analysisLess hyperlipidemiaIschemic complicationsConsecutive patientsCoronary diseaseDiabetes mellitusIndependent predictorsPremature atherosclerosisFactor modification
2003
Outcomes following Bail-Out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)
Ashby DT, Aymong EA, Tcheng JE, Grines CL, Cox DA, Mehran R, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Lansky AJ, Stone GW. Outcomes following Bail-Out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial). The American Journal Of Cardiology 2003, 92: 1091-1094. PMID: 14583362, DOI: 10.1016/j.amjcard.2003.06.005.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplasty, Balloon, CoronaryAntibodies, MonoclonalCross-Over StudiesDrug Administration ScheduleFemaleFollow-Up StudiesHumansImmunoglobulin Fab FragmentsIntraoperative ComplicationsMaleMiddle AgedMyocardial InfarctionPlatelet Glycoprotein GPIIb-IIIa ComplexProspective StudiesTreatment FailureConceptsAcute myocardial infarctionMyocardial infarctionGlycoprotein IIb/IIIa receptor inhibitorsUnsuccessful primary percutaneous coronary interventionIIb/IIIa receptor inhibitorsMyocardial Infarction (TIMI) grade 3 flowPrimary percutaneous coronary interventionGrade 3 flowPercutaneous coronary interventionSuboptimal angioplasty resultsAbciximab administrationCADILLAC trialIschemic complicationsControl patientsCoronary interventionProcedural complicationsAngioplasty resultsReceptor inhibitorsPrimary interventionAbciximabPatientsComplicationsInfarctionLower ratesInterventionRadial artery use is safe in patients with moderate to severe left ventricular dysfunction
Fazel S, Mallidi H, Pelletier M, Sever J, Christakis G, Goldman B, Fremes S. Radial artery use is safe in patients with moderate to severe left ventricular dysfunction. The Annals Of Thoracic Surgery 2003, 75: 1414-1421. PMID: 12735555, DOI: 10.1016/s0003-4975(02)04992-5.Peer-Reviewed Original ResearchConceptsModerate to severe left ventricular dysfunctionLeft ventricular dysfunctionSevere left ventricular dysfunctionRadial artery graftVentricular dysfunctionRadial artery useMyocardial infarctionAortocoronary bypassArterial graftsRate of deathPostoperative deathsArtery useLVD patientsRadial graftCohort analysisPredictive of deathMyocardial infarction rateLogistic regression analysisVasopressor supportIschemic complicationsGraft spasmLogistic regression modelsPatient subgroupsInfarction rateUnmatched group
2001
Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent
Bhargava B, Waksman R, Lansky A, Kornowski R, Mehran R, Leon M. Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent. Catheterization And Cardiovascular Interventions 2001, 54: 295-300. PMID: 11747152, DOI: 10.1002/ccd.1287.Peer-Reviewed Original ResearchConceptsMyocardial infarctionSB occlusionSide branch compromiseCoronary stentingClinical outcomesStent implantationNon-Q-wave myocardial infarctionLate major adverse eventsLong-term clinical outcomesSB compromiseLate target lesion revascularizationHospital ischemic complicationsMore myocardial infarctionsNIR stent implantationMajor adverse eventsTarget lesion revascularizationSide branch occlusionSB patencyBaseline patientIschemic complicationsLesion revascularizationRepeat revascularizationAdverse eventsConsecutive patientsProcedural success
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply